Correction (DOI:10.1016/j.jacc.2009.11.059);The Impact of Changing Medical Therapy on Transplantation-Free Survival in Pediatric Dilated Cardiomyopathy

Journal of the American College of Cardiology

Volumn 55, Issue 13, 2010, Pages 1377-1384

  Kantor, Paul F ^a   Abraham, Jonathan R ^a   Dipchand, Anne I ^a   Benson, Lee N ^a   Redington, Andrew N ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

carvedilol; children; dilated cardiomyopathy; survival

Indexed keywords

ANTHRACYCLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; METOPROLOL;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 77949588239     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.05.006     Document Type: Erratum

References (21)

1. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93 (1996) 841-842
2. Lipshultz S.E., Sleeper L.A., Towbin J.A., et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348 (2003) 1647-1655
3. Towbin J.A., and Bowles N.E. The failing heart. Nature 415 (2002) 227-233
4. Matitiau A., Perez-Atayde A., Sanders S.P., et al. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 90 (1994) 1310-1318
5. Burch M., Siddiqi S.A., Celermajer D.S., Scott C., Bull C., and Deanfield J.E. Dilated cardiomyopathy in children: determinants of outcome. Br Heart J 72 (1994) 246-250
6. Miura K., Nakagawa H., Morikawa Y., et al. Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey. Heart 87 (2002) 126-130
7. Arola A., Tuominen J., Ruuskanen O., and Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 101 (1998) 369-376
8. Dzau V.J., Colucci W.S., Williams G.H., Curfman G., Meggs L., and Hollenberg N.K. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med 302 (1980) 1373-1379
9. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
10. Packer M., Fowler M.B., Roecker E.B., et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106 (2002) 2194-2199
11. Tsirka A.E., Trinkaus K., Chen S.C., et al. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol 44 (2004) 391-397
12. Roge C.L., Silverman N.H., Hart P.A., and Ray R.M. Cardiac structure growth pattern determined by echocardiography. Circulation 57 (1978) 285-290
13. Aretz H.T., Billingham M.E., Edwards W.D., et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1 (1987) 3-14
14. Strauss A., and Lock J.E. Pediatric cardiomyopathy-a long way to go. N Engl J Med 348 (2003) 1703-1705
15. Baldwin J.T., Borovetz H.S., Duncan B.W., et al. The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program. Circulation 113 (2006) 147-155
16. Birks E.J., Tansley P.D., Hardy J., et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355 (2006) 1873-1884
17. Daubeney P.E., Nugent A.W., Chondros P., et al. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 114 (2006) 2671-2678
18. Cox G.F., Sleeper L.A., Lowe A.M., et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 118 (2006) 1519-1531
19. Canter C.E., Shaddy R.E., Bernstein D., et al. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group (correction appears in Circulation 2007;115:e385). Circulation 115 (2007) 658-676
20. Lewis A.B., and Chabot M. The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy. Pediatr Cardiol 14 (1993) 9-12
21. Machin D., Campbell M., Fayers P., and Pinol A. Sample Size Tables for Clinical Studies. 2nd edition (1997), Blackwell Science, Malden, MA